Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease.
暂无分享,去创建一个
C. Pérez | V. Palomo | D. Perez | S. Conde | C. Gil | A. Pérez-Castillo | C. Susín | S. Alonso-Gil | J. Morales-García | A. Martínez | A. Santos